Pharmaceutical Grade Raw Material Antidepressant Raw Material Brexpiprazole Powder CAS 913611-97-9

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: MST-65243
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Test Method: HPLC
• Storage: Store Cool Dry Place
• Market: Worldwide
• CAS: 913611-97-9
• MW: 433.566
• Mf: C25h27n3o2s
• Boiling Point: 675.2±55.0 °c at 760 Mmhg
• Transport Package: Aluminium Foil Bag
• Specification: 99%
• Trademark: Meister
• Origin: China
• Production Capacity: 2000kg/Month

Product Description

Warehouse Providing High Quality Pharmaceutical Grade Raw Material Antidepressant Raw Material Brexpiprazole Powder CAS 913611-97-9 Brexpiprazole

 Meister Supply is an enterprise committed to the development, production. sales and transportaion of chemical products. The company has a long-term cooperative relationship with Bejing Research institute of Chemical Industry and its affliated universities at home and abroad. It is a research and development enterprise of new chemicl materials for the global chemical market demand. "Continuous innovation, quality assurance" is our purpose. It integrates the research and development, industrialization and marketization of innovative chemical new materials. The company has strong technical strength, advanced equipment, strict guality management system and quality afer-sales service. Over the years, our products have been widely sold to many countries and regions, and we have established stable cooperative relations with trades and end users all over the world. Relying on a strong logistics system, we have established our own overseas warehouses in the United States, Mexico, Canada and the Netherlands. Hot local products can be shipped from overseas warehouses. Well received by local customers. It has become a powerful bridge between suppliers, traders and end users. We look forward to more

Product Description

 

 

Brexpiprazole is an atypical antipsychotic drug. It is a D2 dopamine partial agonist called serotonin-dopamine activity modulator (SDAM). The drug received FDA approval on July 13, 2015 for the treatment of schizophrenia, and as an adjunctive treatment for depression.  Although Brexpiprazole failed Phase II clinical trials for ADHD, Brexpiprazole has been designed to provide improved efficacy and tolerability (e.g., less akathisia, restlessness and/or insomnia) over established adjunctive treatments for major depressive disorder (MDD).

Function

Brexpiprazole Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
High doses or long-term use of brexpiprazole can cause a serious movement disorder that may not be reversible. Symptoms of this disorder include uncontrollable muscle movements of your lips, tongue, eyes, face, arms, or legs. 
The longer you take brexpiprazole, the more likely you are to develop a serious movement disorder. The risk of this side effect is higher in women and older adults.

Application

Brexpiprazole Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
High doses or long-term use of brexpiprazole can cause a serious movement disorder that may not be reversible. Symptoms of this disorder include uncontrollable muscle movements of your lips, tongue, eyes, face, arms, or legs. 
The longer you take brexpiprazole, the more likely you are to develop a serious movement disorder. The risk of this side effect is higher in women and older adults.

Detailed Photos

Related product

Shipping&Payment